A Study Of PF-03732010 In Patients With Advanced Solid Tumors
NCT00557505
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
PF-03732010
Sponsor
Pfizer